mortality/aging
• mean age of death is 2.6 months +/- 1.8 months
|
• partial embryonic lethality at day E14-E16
|
neoplasm
• 20% of animals displayed metastatic thymic lymphomas at 4-7 months of age
|
• 1 animal displayed myeloid leukemia
|
growth/size/body
• weight of mutant mice was 60% of controls
|
• 4 animals displayed splenic hyperplasia
|
hematopoietic system
• abnormal thymus architecture
|
• 20% of animals displayed metastatic thymic lymphomas at 4-7 months of age
|
• at 1 week of age mutant mice displayed a 2-3 fold increase in pro B cells
|
• at 4 weeks of age mutant mice displayed severe depletion of lymphocytes, macrophages, red blood cells, and platelets
|
• bone marrow devoid of hematopoietic cells and composed largely of adipocytes
|
• splenic B cell count at 4.8%-12% of wild-type
|
• at 1 week of age mutant mice displayed a 1.5-3 fold reduction in immature B cell population
|
• at 1 week of age mutant mice displayed a 1.5-3 fold reduction in pre B cell population
|
• splenic T cell count at 7%-49% of wild-type
|
• at 1 week of age mutant mice displayed a 2-3 fold increase in macrophages
|
• abnormal spleen architecture
|
• 4 animals displayed splenic hyperplasia
|
immune system
• at 1 week of age mutant mice displayed a 2-3 fold increase in pro B cells
|
• splenic B cell count at 4.8%-12% of wild-type
|
• at 1 week of age mutant mice displayed a 1.5-3 fold reduction in immature B cell population
|
• at 1 week of age mutant mice displayed a 1.5-3 fold reduction in pre B cell population
|
• splenic T cell count at 7%-49% of wild-type
|
• at 1 week of age mutant mice displayed a 2-3 fold increase in macrophages
|
• abnormal thymus architecture
|
• 20% of animals displayed metastatic thymic lymphomas at 4-7 months of age
|
• abnormal spleen architecture
|
• 4 animals displayed splenic hyperplasia
|
endocrine/exocrine glands
• abnormal thymus architecture
|
• 20% of animals displayed metastatic thymic lymphomas at 4-7 months of age
|